People with Type 2 Diabetes have difficulty regulating their glucose – or blood sugar – levels, particularly after meals. Now, University of Missouri researchers have found that Type 2 diabetics can eat more protein at breakfast to help reduce glucose spikes at both breakfast and lunch. “People often assume that their glucose response at one meal will … Continue reading Prevent Type 2 Diabetes Blood-Sugar Spikes by Eating More Protein for Breakfast
The FDA wants to take another look at a pill approved in 2006 for control of glucose levels in people with type 2 diabetess. In a trial study published in the New England Journal of Medicine, saxagliptin (brand name Onglyza) was shown to coincide with an increased rate of hospitalization for heart failure of 27 … Continue reading Saxagliptin- Oral Medication Caution
BROOMFIELD, Colo.–MicroBiome TherapeuticsTM has announced positive results from its clinical trial of a microbiome modulator, NM504, in development for type 2 diabetes and pre-diabetes. NM504 is designed to improve glucose tolerance and other metabolic parameters in patients with diabetes by shifting the gastrointestinal microbiome–the micro-organisms that inhabit the human body. Studies have shown that people … Continue reading Successful Clinical Trial of Type 2 Drug That Works on Intestinal Organisms
Insulin may not be the best first line of defense for women who develop gestational diabetes, according to the results of a new study. Research out of São Paulo, Brazil, suggests that for a majority of women who develop diabetes during pregnancy, metformin alone can lower blood glucose and neonatal hypoglycemia rates. During pregnancy, the … Continue reading Metformin Better Than Insulin for Gestational Diabetes?
Hypoglycemia remains a complex issue for diabetes patients and their healthcare providers, according to the focus of a recent symposium. Experts from across the globe spoke as part of an American Diabetes Association program, bringing to light some of the key concerns for those managing hypoglycemia in diabetes patients. From inadequate use of continuous glucose … Continue reading Experts Target Hypoglycemia at ADA Conference
Working toward the goal of unifying patients’ diabetic treatment information in a single place, the PositiveID Corporation hopes to patent a new device that monitors insulin pens. The Insulin Tracker would attach to a user’s insulin pen and record the times and amounts of injections. That information would then be sent to a database that allows … Continue reading Type 1 & Type 2 Diabetes: iGlucose